Search results
On doorstep of approval, Merck compares V116 pneumococcal vaccine to 1983 warhorse Pneumovax 23
FierceBiotech· 2 days agoFive months ago, Merck revealed data that indicate its next-generation pneumococcal vaccine offers more protection for older adults than Pfizer’s market dominator Prevnar ...
Should You Buy Moderna Before May 12?
Motley Fool via Yahoo Finance· 5 days agoThe biotech company aims to bring as many as 15 new products to market over the next five years and has the late-stage pipeline to support...is set to...
Analysts Expect Moderna's First-Quarter Sales To Plummet 95% — Is Moderna Stock A Sell?
Investor's Business Daily· 6 days agoThe RS Rating is a 1-99 measure of a stock's 12-month performance. This means Moderna stock outranks...
Biotech Stocks Facing FDA Decision In May 2024
RTT News· 11 hours agoAs April comes to an end, attention shifts to biotech stocks poised for regulatory events in May. The FDA approved eight novel drugs last May, contributing to a total of 55 approvals ...
FDA Says Vaccination Is the Best Protection Against Measles
Sierra Sun Times· 2 days agoMeasles is one of the most contagious respiratory diseases in the world that has the potential to be life-threatening. Vaccines approved by the U.S. Food and Drug Administration ...
Is Pfizer Stock A Sell As Shares Hit An 11-Year Low Amid The Search For Its Next Big Break?
Investor's Business Daily· 6 days agoThe RS Rating measures a stock's 12-month running performance against all other stocks. That RS...
Merck (MRK) Q1 Earnings Top, Cancer Drug Keytruda Boosts Sales
Zacks via Yahoo Finance· 6 days agoQuarter in Detail The Pharmaceutical segment generated revenues of $14.0 billion, up 9% year over...
5 Top Stocks to Buy in May
Motley Fool via Yahoo Finance· 17 hours agoThe good news, though, is that the company's year-over-year comparisons should be less challenging after this year. Pfizer could even enjoy a rebound in...
FDA finalizes lab test regulations with more flexibility
Politico· 13 hours agoNordic has started submitting data to the FDA for approval of its chikungunya vaccine, aiming to complete the submission by the end of June, the company ...
Merck & Co., Inc. (NYSE:MRK) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 16 hours agoMerck & Co., Inc. (NYSE:MRK) Q1 2024 Earnings Call Transcript April 25, 2024 Merck & Co., Inc. beats...
